Health & Medicine

STAT+: How an outsider crept into Eli Lilly's top ranks - and plans to drive its business forward

Ali Nemati1 day ago28 sec read9 views

Eli Lilly unexpectedly acquired Loxo Oncology for $8 billion in 2019, bringing not just cancer drugs and research but also key executives like Jacob Van Naarden into its leadership, marking an uncommon "acqui-hire" strategy in the pharmaceutical industry. This move underscores the value of strategic talent acquisition in driving business forward, highlighting a significant shift for content creators to note when covering corporate strategies in pharma.

Read the full article at STAT News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Comments

USPTO Has a Free Patent API - Search 8M+ Patents (No Key Required)

This article provides a guide on how to programmatically search patents using Python and APIs, offering various use cases such as identifying new technologies, researching company R&D activity, and investment analysis. It includes sample code sni...

Ali Nemati

AI & Machine Learning2 days ago21 sec read

Deciphering Scientific Reasoning Steps from Outcome Data for Molecule Optimization

Researchers propose DESRO, a framework that uses large language models to infer scientific reasoning steps from experimental outcomes, focusing on molecule optimization in drug discovery. This breakthrough enables automated and interpretable scientif...

Ali Nemati

Sustainability & ClimateMar 1628 sec read

Is the world heating up faster than we thought?

A recent study suggests global warming has accelerated rapidly over the past decade, with temperatures rising almost twice as fast compared to previous periods. This acceleration puts us closer to crossing critical climate tipping points, such as des...

Ali Nemati

Health & MedicineMar 1220 sec read

Opinion: STAT+: It's the 50th anniversary of the U.S. biotech industry. What will the next 50 years look like?

The U.S. biotech industry celebrates its 50th anniversary since Genentech's founding in 1976, marking significant advancements in health and job creation; as content creators focus on this milestone, they should highlight the potential for future inn...

Ali Nemati

Tech & GadgetsMar 1030 sec read

Trump's divisive FDA vaccine regulator self-destructs, will exit agency (again)

Vinay Prasad, a controversial figure at the FDA, is set to leave the agency again in April after a tumultuous tenure marked by decisions that overruled scientific consensus and created a toxic work environment. His departure highlights the risks of p...

Ali Nemati

STAT+: How an outsider crept into Eli Lilly's top ranks - and plans to drive its business forward

Related Articles

USPTO Has a Free Patent API - Search 8M+ Patents (No Key Required)

Deciphering Scientific Reasoning Steps from Outcome Data for Molecule Optimization

Is the world heating up faster than we thought?

Opinion: STAT+: It's the 50th anniversary of the U.S. biotech industry. What will the next 50 years look like?

Trump's divisive FDA vaccine regulator self-destructs, will exit agency (again)